What can we learn from an unrepresentative population screening for hypertension? by Saint-Remy, Annie et al.
WHAT CAN WE LEARN FROM A UNREPRESENTATIVE POPULATION 
SCREENING FOR HYPERTENSION ? 
A. Saint-RemyA, C. Moritz*, J. Narinx*, Ch. Van Severen*, S. Van Steenberge*,  
A. Wozolek* and JM. KrzesinskiA   
(A) Nephrology-Hypertension-Transplantation; * Medical student Uliège 
 
AIM: May Measurement Month (MMM) survey was initiated by ISH and approached more 
than 100 countries for contribution to improve awareness of hypertension (HT) which remains 
a worldwide problem. Present study reports the statistics for a belgian regional screening 
organized in May 2017 in the University Hospital of Liege.  
METHOD:468 participants (≥18 years) attended a 4 days screening, they were interviewed to 
collect: weight, height, antihypertensive treatment, diabetes, smoking, alcohol consumption and 
history of cv events. Three consecutive BP measurements were done with Omron M6. 
Participants received advices on how to maintain a good cv health and a card with their BP to 
share with their physician. Those with high BP (≥140 and/or ≥ 90 mmhg) received explanations 
on their readings and actions needed. We added questions on Home Blood Pressure (HBP) to 
assess the frequency of people who practice HBP and the importance they gave it in the 
management of HT by physicians. 
RESULTS: 91% of participants were white, mean age: 52.2±18, women: 56%, 10% had 
diabetes, 23% were current smokers, less than 5% had a history of heart attack or stroke. 
Alcohol consumption was regular in 40%. As a whole, HT was identified in 23% and 1/3 were 
treated. In those treated, BP was uncontrolled in 31.5%. No significant difference of cv profile 
was found between uncontrolled and controlled treated participants. However, the untreated HT 
were significantly older, had a higher BMI and a higher consumption of alcohol than untreated 
NT. At home,52 % had an HBP monitor and measured their BP 5 times/month on average. 
When treated, at least 50% being either controlled or not considered that HBP should be 
integrated by the physician into the management of their HT. 
CONCLUSION: Despite the limits of such tool to assess prevalence of HT, screening offered 
a great opportunity to inform people on HT and cv risks, on how correctly measure BP and on 
the importance of adherence to treatment. 
  
 
 
